This country profile provides an overview of Burkina Faso’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profiles

Treatment coverage

Elephantiasis
76%
Blinding trachoma
100%
Intestinal worms
100%
Bilharzia
86%
River blindness
80%
5.94 million people received treatment in Burkina Faso in 2017 0.59 million people did not receive treatment in Burkina Faso in 2017

Priorities for progress in Burkina Faso

  • Burkina Faso is commended for consistently high coverage rates across the board.
  • As a next step, work to maintain this high coverage and progress towards elimination.
  • Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.

Elephantiasis

Treatment coverage increased from 64% in 2016 to 76% in 2017.

People needing treatment
5.53m
People receiving treatment
4.23m

Blinding trachoma

Treatment coverage remained at 100% in 2016 and 2017.

People needing treatment
Surveillance
People receiving treatment
Not applicable

Intestinal worms

Treatment coverage remained at 100% in 2016 and 2017.

Pre-sch and school-aged children needing treatment
Surveillance
Pre-school and school-aged children receiving treatment
Not applicable

Bilharzia

Treatment coverage decreased from 88% in 2016 to 86% in 2017.

School-aged children needing treatment
2.67m
School-aged children receiving treatment
2.31m

River blindness

Treatment coverage decreased from 95% in 2016 to 80% in 2017.

People needing treatment
0.26m
People receiving treatment
0.21m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in Burkina Faso.